Anti-SLAMF7 antibodies are used in the immunodetection of the protein SLAM family member 7. In humans, the canonical protein has a reported length of 335 amino acid residues and a mass of 37.4 kDa. Its subcellular localization is in the membrane. Up to 7 different isoforms have been reported for this protein. It is reported to be expressed in spleen, lymph node, peripheral blood leukocytes, bone marrow, small intestine, stomach, appendix, lung and trachea. SLAMF7 is reported to be a self-ligand receptor of the signaling lymphocytic activation molecule (SLAM) family. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include CD2 subset 1, CD2-like receptor activating cytotoxic cells, membrane protein FOAP-12, novel LY9 (lymphocyte antigen 9) like protein, protein 19A, and 19A24 protein. SLAMF7 gene orthologs have been reported in the mouse, rat, bovine and chimpanzee species.